Efficacy of Vedolizumab for Inflammatory Bowel Disease in the Setting of DiGeorge Syndrome

被引：2
|
作者：
Thau, Eve [1 ]
Moore, Hillary Aaron [1 ]
Stein, Philip [1 ]
Chen, Kathy [1 ]
机构：
[1] Drexel Univ, St Christophers Hosp Children, Coll Med, Dept Pediat,Sect Gastroenterol Hepatol & Nutr, Philadelphia, PA 19104 USA
来源：
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION | 2019年 / 68卷 / 05期
关键词：
MAINTENANCE THERAPY; INDUCTION;
D O I：
10.1097/MPG.0000000000002322
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：E88 / E88
页数：1
相关论文
共 50 条
  • [21] Vedolizumab and Extraintestinal Manifestations in Inflammatory Bowel Disease
    Jurij Hanzel
    Christopher Ma
    Niels Vande Casteele
    Reena Khanna
    Vipul Jairath
    Brian G. Feagan
    Drugs, 2021, 81 : 333 - 347
  • [22] Vedolizumab for inflammatory bowel diseases: proper use and efficacy
    Renault-Mahieux, Morgane
    Akrout, Wiem
    Cohen, Ilan
    Cordonnier-Jourdin, Catherine
    Amiot, Aurelien
    Paul, Muriel
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2018, 40 (01) : 288 - 288
  • [23] Efficacy of adalimumab for the management of Inflammatory Bowel Disease in the Clinical Setting
    Trinder, Matthew W.
    Lawrance, Ian C.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 (07) : 1252 - 1257
  • [24] Efficacy of Vedolizumab as Induction Therapy for Inflammatory Bowel Disease in a 'real-life' Study
    Trefois, Quentin
    Descamps, Olivier
    Coche, Jean-Charles
    Schapira, Michael
    ACTA CLINICA BELGICA, 2016, 71 : 7 - 7
  • [25] Efficacy and Safety of Vedolizumab in Patients with Inflammatory Bowel Disease in a Large Tertiary Medical Center
    Wice, Mitchell
    Oppenheim, Shannon
    Miller, Hannah
    Wasan, Sharmeel
    Noronha, Ansu
    Rybin, Denis
    Weinberg, Janice
    Farraye, Francis A.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S270 - S270
  • [26] EFFICACY AND SAFETY OF VEDOLIZUMAB FOR INFLAMMATORY BOWEL DISEASE IN THE UK POPULATION:SINGLE CENTRE EXPERIENCE
    Aleem, Muhammad Junaid
    Mozdiak, Ella
    Saeed, Omar Muhammad
    Champsi, Asgher
    Hameed, Kashif
    Lakhani, Hammad
    Monga, Muhammad Ali
    GUT, 2021, 70 : A109 - A109
  • [27] Efficacy of combination vedolizumab and upadacitinib treatment in refractory inflammatory bowel disease: a case series
    Swe, Ei Phyu Phyu
    Gilmore, Robert
    Murali, Amrutha
    Etchegaray, Amirah
    Fernandes, Richard
    An, Yoon-Kyo
    Begun, Jakob
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 : 244 - 245
  • [28] Vedolizumab has no efficacy on articular manifestations in patients with spondyloarthritis associated with inflammatory bowel disease
    Paccou, Julien
    Nachury, Maria
    Duchemin, Cedric
    Desreumaux, Pierre
    Flipo, Rene-Marc
    Pariente, Benjamin
    JOINT BONE SPINE, 2019, 86 (05) : 654 - 656
  • [29] Efficacy of vedolizumab in patients with inflammatory bowel disease and failure of anti-TNF-antibodies
    Hoog, C.
    Eberhardson, M.
    Almer, S.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S310 - S310
  • [30] Benefit of measuring vedolizumab concentrations in inflammatory bowel disease patients in a real-world setting
    Kolehmainen, Sara
    Ylisaukko-Oja, Tero
    Jokelainen, Jari
    Koivusalo, Mirkka
    Jokiranta, T. Sakari
    Sipponen, Taina
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2021, 56 (08) : 906 - 913
12345